J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial

European Heart Journal

Volumn 31, Issue 23, 2010, Pages 2897-2908

  Bangalore, Sripal ^a   Messerli, Franz H ^b   Wun, Chuan Chuan ^c   Zuckerman, Andrea L ^c   Demicco, David ^c   Kostis, John B ^d   Larosa, John C ^e  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c PFIZER INC   (United States)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Blood pressure; J Curve; TNT trial

Indexed keywords

ATORVASTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRINITROTOLUENE;

ADULT; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE MONITORING; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DRUG TARGETING; FEMALE; HEART ARREST; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONLINEAR SYSTEM; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RESUSCITATION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEART ARREST; HEPTANOIC ACIDS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PYRROLES; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 78649891370     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq328     Document Type: Article

References (27)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289: 2560-2572. (Pubitemid 37430158)
2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913.
3. Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A, Kolloch R, Benetos A, Pepine CJ. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 2006;144:884-893.
4. Protogerou AD, Safar ME, Iaria P, Safar H, Le Dudal K, Filipovsky J, Henry O, Ducimetiere P, Blacher J. Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension 2007;50:172-180.
5. Weinberger MH. Do no harm. Antihypertensive therapy and the 'J' curve. Arch Intern Med 1992;152:473-476.
6. Staessen JA. Potential adverse effects of blood pressure lowering-J-curve revisited. Lancet 1996;348:696-697.
7. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet 1987;1:581-584.
8. Farnett L, Mulrow CD, Linn WD, Lucey CR, Tuley MR. The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? JAMA 1991;265:489-495.
9. Waller PC, Isles CG, Lever AF, Murray GD, McInnes GT. Does therapeutic reduction of diastolic blood pressure cause death from coronary heart disease? J Hum Hypertens 1988;2:7-10.
10. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-1762. (Pubitemid 28269185)
11. Waters DD, Guyton JR, Herrington DM, McGowan MP, Wenger NK, Shear C. Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit? Am J Cardiol 2004;93:154-158.
12. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK. Intensive lipid lowering with ator-vastatin in patients with stable coronary disease. N Engl J Med 2005;352: 1425-1435.
13. Cox DR. Regression Models and Life Tables (with Discussion). J R Stat Soc 1972; 34:187-220.
14. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551-561.
15. Heinzl H, Kaider A. SAS Technical Report KB-1-96: manual for the SAS macro RCS (version 2.0).
16. Stewart IM. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet 1979;1:861-865.
17. Untreated mild hypertension. A report by the Management Committee of the Australian Therapeutic Trial in Mild Hypertension. Lancet 1982;1:185-191.
18. Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group. J Hypertens 1985;3:379-392.
19. Lindholm L, Lanke J, Bengtsson B, Ejlertsson G, Thulin T, Schersten B. Both high and low blood pressures risk indicators of death in middle-aged males. Isotonic regression of blood pressure on age applied to data from a 13-year prospective study. Acta Med Scand 1985;218:473-480.
20. D'Agostino RB, Belanger AJ, Kannel WB, Cruickshank JM. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study. BMJ 1991;303:385-389.
21. Voko Z, Bots ML, Hofman A, Koudstaal PJ, Witteman JC, Breteler MM. J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension 1999;34:1181-1185.
22. Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel JP. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med 2002;136:438-448.
23. Fagard RH, Staessen JA, Thijs L, Celis H, Bulpitt CJ, De Leeuw PW, Leonetti G, Tuomilehto J, Yodfat Y. On-treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med 2007;167:1884-1891.
24. Boshuizen HC, Izaks GJ, Van Buuren S, Ligthart GJ. Blood pressure and mortality in elderly people aged 85 and older: community based study. BMJ 1998;316: 1780-1784.
25. Tuomilehto J, Ryynanen OP, Koistinen A, Rastenyte D, Nissinen A, Puska P. Low diastolic blood pressure and mortality in a population-based cohort of 16913 hypertensive patients in North Karelia, Finland. J Hypertens 1998;16:1235-1242.
26. Kannel WB, Wilson PW, Nam BH, D'Agostino RB, Li J. A likely explanation for the J-curve of blood pressure cardiovascular risk. Am J Cardiol 2004;94:380-384.
27. Cushman WC, Evans GW, Byington RP, Goff Jr. DC, Grimm Jr. RH, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;362: 1575-1585.